BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2506606)

  • 1. Effect of physostigmine on memory consolidation and retrieval processes in intact and nucleus basalis-lesioned rats.
    Santucci AC; Kanof PD; Haroutunian V
    Psychopharmacology (Berl); 1989; 99(1):70-4. PubMed ID: 2506606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frontal cortex as the site of action of physostigmine in nbM-lesioned rats.
    Haroutunian V; Mantin R; Kanof PD
    Physiol Behav; 1990 Jan; 47(1):203-6. PubMed ID: 2326337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous physostigmine infusion in rats with excitotoxic lesions of the nucleus basalis magnocellularis: effects on performance in the water maze task and cortical cholinergic markers.
    Mandel RJ; Chen AD; Connor DJ; Thal LJ
    J Pharmacol Exp Ther; 1989 Nov; 251(2):612-9. PubMed ID: 2810114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Learning and memory deficits after lesions of the nucleus basalis magnocellularis: reversal by physostigmine.
    Murray CL; Fibiger HC
    Neuroscience; 1985 Apr; 14(4):1025-32. PubMed ID: 4000475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of continuous infusion of cholinergic drugs on memory impairment in rats with basal forebrain lesions.
    Miyamoto M; Narumi S; Nagaoka A; Coyle JT
    J Pharmacol Exp Ther; 1989 Feb; 248(2):825-35. PubMed ID: 2918482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further characterizations of the nature of the behavioral and neurochemical effects of lesions to the nucleus basalis of Meynert in the rat.
    Altman HJ; Crosland RD; Jenden DJ; Berman RF
    Neurobiol Aging; 1985; 6(2):125-30. PubMed ID: 4022231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilocarpine and physostigmine attenuate spatial memory impairments produced by lesions of the nucleus basalis magnocellularis.
    Murray CL; Fibiger HC
    Behav Neurosci; 1986 Feb; 100(1):23-32. PubMed ID: 3954876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of scopolamine and physostigmine on recognition memory in monkeys with ibotenic-acid lesions of the nucleus basalis of Meynert.
    Aigner TG; Mitchell SJ; Aggleton JP; DeLong MR; Struble RG; Price DL; Wenk GL; Mishkin M
    Psychopharmacology (Berl); 1987; 92(3):292-300. PubMed ID: 3114781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of THA on passive avoidance retention performance of intact, nucleus basalis, frontal cortex and nucleus basalis + frontal cortex-lesioned rats.
    Riekkinen P; Sirviö J; Riekkinen M; Riekkinen P
    Pharmacol Biochem Behav; 1991 Aug; 39(4):841-6. PubMed ID: 1763101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological alleviation of cholinergic lesion induced memory deficits in rats.
    Haroutunian V; Kanof P; Davis KL
    Life Sci; 1985 Sep; 37(10):945-52. PubMed ID: 4040999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similar memory impairments found in medial septal-vertical diagonal band of Broca and nucleus basalis lesioned rats: are memory defects induced by nucleus basalis lesions related to the degree of non-specific subcortical cell loss?
    Riekkinen P; Sirviö J; Riekkinen P
    Behav Brain Res; 1990 Feb; 37(1):81-8. PubMed ID: 2310496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infusion of NMDA into the nucleus basalis of Meynert, frontal cortex or lateral ventricle in rats: effect on memory and cholinergic brain neurochemistry.
    Santucci AC; Kanof PD; Haroutunian V
    Pharmacol Biochem Behav; 1989 Jun; 33(2):485-8. PubMed ID: 2682674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleus basalis magnocellularis lesions: lack of biochemical and immunocytochemical recovery and effect of cholinesterase inhibitors on passive avoidance.
    Thal LJ; Dokla CP; Armstrong DM
    Behav Neurosci; 1988 Dec; 102(6):852-60. PubMed ID: 3214535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of cholinergic drugs and lesions of nucleus basalis or fimbria-fornix on delayed matching in rats.
    Dunnett SB
    Psychopharmacology (Berl); 1985; 87(3):357-63. PubMed ID: 3936093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p-Chloroamphetamine blocks physostigmine-induced memory enhancement in rats with unilateral nucleus basalis lesions.
    Santucci AC; Haroutunian V
    Pharmacol Biochem Behav; 2004 Jan; 77(1):59-67. PubMed ID: 14724042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetrahydroaminoacridine improves the spatial acquisition deficit produced by nucleus basalis lesions in rats.
    Kwo-On-Yuen PF; Mandel R; Chen AD; Thal LJ
    Exp Neurol; 1990 Jun; 108(3):221-8. PubMed ID: 2351210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of memory and cortical cholinergic neurochemical recovery with combine fetal transplantation and GM1 treatments in rats with lesions of the NBM.
    Santucci AC; Gluck R; Kanof PD; Haroutunian V
    Dementia; 1993; 4(5):273-81. PubMed ID: 8261024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physostigmine improves water maze performance following nucleus basalis magnocellularis lesions in rats.
    Mandel RJ; Thal LJ
    Psychopharmacology (Berl); 1988; 96(3):421-5. PubMed ID: 3146779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of sleep parameters and memory in intact old rats and young rats with lesions in the nucleus basalis magnocellularis.
    Stone WS; Altman HJ; Berman RF; Caldwell DF; Kilbey MM
    Behav Neurosci; 1989 Aug; 103(4):755-64. PubMed ID: 2765180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recovery of neocortical choline acetyltransferase activity following ibotenic acid injection into the nucleus basalis of Meynert in rats.
    Wenk GL; Olton DS
    Brain Res; 1984 Feb; 293(1):184-6. PubMed ID: 6704718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.